Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akeso, Ascentage, Bioatla, Biomind, Biontech, Laurent, NGM, Pfizer, Rain, Redhill, Vicore.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abeona, Actinium, Aelix, Albireo, Apeiron, Aramis, Arbutus, Ardelyx, Atea, Biontech, Biophytis, Blaze, Chinook, Clairvoyant, Compass, Daewoong, Emergent, G1, GSK, Inozyme, Lianbio, Madrigal, Neurocrine, Neurotech, Ose, Pfizer, Regenxbio, Regulus, Renovion, Rhythm, Rigel, Sagimet, Sonnet, Surface Oncology, Syndax, Theriva, Transgene, Uniqure, Vectivbio.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Daxor, Sight Sciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allurion, Bluestar Genomics, Surmodics, Terumo Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akston, Biothera, Cingulate, Denali, Dragonfly, Ensysce, Harmony, Hoth, Merck, Monte Rosa, Orum, Pfizer, Pieris, Promore, Receptor, Remegen, Stealth, Teon, Unity, Xeris.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: 1st Biotherapeutics, Apogenix, Bavarian Nordic, Brii, Everest Medicines, Gracell, Harbour Biomed, Innovent Biologics, Inxmed, Kintor, Moderna, Providence, Radiopharm, Revive, Sorrento, Spikimm, Telix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Caredx, Inari Medical, Synaps Dx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acelrx, Actinium, Akeso, BMS, Cerecin, Disc, Essa, First Wave, Innocare, Innovent, Instil, Kalvista, Merck & Co., Nicox, Pharmazz, Scancell, Senhwa, United Therapeutics, Vaccitech, Verge.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cleveland Diagnostics, Preludedx.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edgewise, Morphosys, Nuvalent, Quantum Genomics, Sanofi, Sciwind, Urovant Sciences, Vyluma.